Publication Name	World Journal of Clinical Oncology
Manuscript ID	11079
Country	India

Received	2014-05-03 19:03
Peer-Review Started	2014-05-04 10:51
To Make the First Decision	2014-05-14 13:42
Return for Revision	2014-05-16 16:44
Revised	2014-07-19 01:14
Second Decision	2014-10-10 18:00
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2014-10-10 18:12
Articles in Press	2014-10-10 18:12
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-11-18 09:06
Publish the Manuscript Online	2014-12-11 14:23

ISSN	2218-4333 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Topic Highlights
Article Title	Erlotinib usage after prior treatment with gefitinib in advanced non-small cell lung cancer: A clinical perspective and review of published literature
Manuscript Source	Invited Manuscript
All Author List	Navneet Singh, Aditya Jindal and Digambar Behera
Funding Agency and Grant Number
Corresponding Author	Navneet Singh, MD, DM, FACP, FCCP, FICS, Assistant Professor, Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Sector 12, Chandigarh 160012, India. singh.navneet@pgimer.edu.in
Key Words	Gefitinib; Erlotinib; Non-small cell lung cancer; Epidermal growth factor receptor; Tyrosine kinase inhibitor
Core Tip	This manuscript is focused on the controversial yet interesting topic of whether erlotinib provides clinical benefit amongst patients who have experienced disease progression after prior therapy with gefitinib-both drugs being tyrosine kinase inhibitors of the epidermal growth factor receptor. We have reviewed available literature on this topic, carried out a pooled analysis on available data and hope readers find it useful in clearing the confusion related to this topic.
Publish Date	2014-12-11 14:23
Citation	Singh N, Jindal A, Behera D. Erlotinib usage after prior treatment with gefitinib in advanced non-small cell lung cancer: A clinical perspective and review of published literature. World J Clin Oncol 2014; 5(5): 858-864
URL	http://www.wjgnet.com/2218-4333/full/v5/i5/858.htm
DOI	http://dx.doi.org/10.5306/wjco.v5.i5.858

Full Article (PDF)	WJCO-5-858.pdf
Full Article (Word)	WJCO-5-858.doc
Manuscript File	11079-Review.docx
Answering Reviewers	11079-Answering reviewers.pdf
Copyright License Agreement	11079- Copyright assignment.pdf
Peer-review Report	11079-Peer review(s).pdf
Scientific Misconduct Check	11079-CrossCheck.jpg
Scientific Editor Work List	11079-Scientific editor work list.pdf